Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies
Anti-CD7 Universal CAR-T Cells for CD7+ T/NK Cell Hematologic Malignancies: a Multi-center, Uncontrolled Trial
Sponsor: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
A EARLY_PHASE1 clinical study on T-cell Leukemia and T-cell Lymphoma, this trial is ongoing. The trial is conducted by 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China and has accumulated 9 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Unknown EARLY_PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Unknown EARLY_PHASE1
-
Aug 2024 — Sep 2024 [monthly]
Unknown EARLY_PHASE1
-
Jul 2024 — Aug 2024 [monthly]
Unknown EARLY_PHASE1
Status: Unknown Status → Unknown
-
Jul 2023 — Jul 2024 [monthly]
Unknown Status EARLY_PHASE1
Status: Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Apr 2023 — Jul 2023 [monthly]
Recruiting EARLY_PHASE1
-
Sep 2021 — Apr 2023 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Mar 2020 — Jan 2021 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
- Central South University
- First Affiliated Hospital of Kunming Medical University
- Fujian Medical University Union Hospital
- Gracell Biotechnologies (Shanghai) Co., Ltd.
- Nanfang Hospital, Southern Medical University
- Second Affiliated Hospital of Xi'an Jiaotong University
- Tang-Du Hospital
- The Affiliated Hospital Of Guizhou Medical University
- The First Affiliated Hospital of Anhui Medical University
- The General Hospital of Western Theater Command
- The Second Affiliated Hospital of Chongqing Medical University
- Xinqiao Hospital of Chongqing
For direct contact, visit the study record on ClinicalTrials.gov .